What Medicover Integrated Clinical Services does

Medicover Integrated Clinical Services (MICS) is the clinical-research services arm of Stockholm-listed Medicover Group, operating under the legal entity Belro Medical S.A. (Belgium) with headquarters in Gdańsk, Poland. Its predecessor entity Nova Medical was founded in 1996. MICS provides integrated clinical-trial services to pharmaceutical, biotechnology, and medical-device sponsors, structured around three pillars: Central Laboratory services with a 12,000+ assay menu, Precision Medicine capabilities supporting biomarker-driven protocols, and a Site Management Organization (SMO) that operates investigator sites and coordinates patient-facing trial activities. The business is delivered against a stack of accepted credentials that includes ICH GCP, GCLP, ISO 17025, ISO 15189, and 21 CFR Part 11 — gating qualifications for regulated clinical-trial work.

MICS has supported more than 750 clinical trials across 50+ countries. Its commercial model is sales-led and event-driven, anchored by long-duration protocols that lock sponsors into the company for the duration of each study and produce recurring specimen-, site-, and project-management revenue streams per active trial. Recent partnerships with ARUP Laboratories (December 2023) and Frontage Laboratories (November 2024) extend its testing reach into US and China sponsor networks, while a 2025 acquisition of selected SYNLAB Group operations adds Romania, Turkey, Cyprus, Slovenia, Croatia, and North Macedonia to the geographic footprint alongside 675+ clinical professionals.

Post-acquisition headcount exceeds 675 plus a 137-employee base, and combined operations span central-lab testing, bioanalytical and biomarker work, and investigator site management. Service revenue is generated through per-protocol central-lab testing fees, SMO site-management contracts, and precision-medicine program fees tied to the complexity and duration of each sponsor engagement.

Name

Medicover Integrated Clinical Services

Legal name

Belro Medical S.A.

Website

https://medicover-mics.com

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

101–250 employees

Short description

Medicover Integrated Clinical Services provides integrated clinical-trial services — central-lab testing, precision-medicine, and site management — to pharmaceutical, biotech, and medical-device sponsors across 50+ countries, operating under Stockholm-listed Medicover Group.

Ownership category

akta.pro rank

Product category

Clinical Trial Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731), In Vitro & In Vivo Diagnostic Substances (2835), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE)

akta.pro secondary industries

Clinical Trial Site Operations & Study Coordination (HLAGACAE), Clinical CROs (Phase I–IV) (HLAGAAAA), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC), Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

Keywords

• Clinical laboratory services
• Clinical trial support
• Precision medicine services
• Site management organisation
• Companion diagnostics development

Headquarters

HQ city

Waterloo

HQ country

Belgium

HQ region

Europe

Offices19 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Clinical Laboratory Services: Fee-for-service model providing central laboratory services, precision medicine, and site management organisation services to pharmaceutical, biotech, biopharma, and CRO companies. Services are priced per project or study basis with customized pricing based on scope.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Medicover Integrated Clinical Services delivers an integrated clinical trial ecosystem for pharmaceutical, biotech, biopharma and CRO sponsors, combining Central Lab Services (sample collection, processing, testing and reporting with global coverage), Precision Medicine (biomarker discovery, companion diagnostic assay development and commercialization), Site Management Organisation services (site selection, feasibility, patient recruitment and monitoring through owned MICS Medical Centers), and a broader Laboratory Services platform of over 12,000 validated assays. Customers contract for customized, project-based engagements across all phases of clinical development, supported by the proprietary LabOne electronic laboratory results system.

Product overview

Medicover Integrated Clinical Services (MICS) is a specialized business unit of Medicover Group offering an integrated clinical trial ecosystem. The portfolio consists of three core service lines: Central Lab Services (comprehensive laboratory support with global coverage), Precision Medicine (multi-omics services including companion diagnostics development), and Site Management Organisation (patient recruitment and site management). Supporting these core services is the Laboratory Services platform offering over 12,000 validated assays, the LabOne Electronic Laboratory Results System for sample tracking, and a network of owned MICS Medical Centers. The company also provides end-to-end companion diagnostics services. Together, these services enable sponsors and CROs to conduct clinical trials from patient recruitment through laboratory analysis, with integrated precision medicine capabilities for targeted therapy development.

Differentiator

Problem solved

Functional benefit

Products and services

• Central Lab Services Comprehensive services to coordinate every aspect of clinical trial laboratory operations, including sample collection, processing, testing and reporting with global coverage across 50+ countries for pharmaceutical, biotech, biopharma and CRO sponsors.
• Precision Medicine Multi-omics services for full therapy development, including biomarker discovery, target validation, companion diagnostic assay development, commercialization, and regulatory services for companion diagnostics.
• Site Management Organisation (SMO) Global access to patients for successful and patient-centric clinical trials, providing site selection, feasibility assessments, patient recruitment support, regulatory compliance and monitoring services through owned MICS Medical Centers and acquired sites in Poland and Germany.
• Laboratory Services Over 12,000 validated assays across all major clinical pathology areas, ranging from routine to advanced tests including immunoassays, genomics, cell-based assays, histology, RT-PCR, flow cytometry, HPLC, coagulation, enzymatic assays, platelet function assays and multiplex assays.
• Companion Diagnostics End-to-end companion diagnostics development, commercialization and implementation services including biomarker identification, diagnostic assay development, regulatory support for CDx approvals, and integration into clinical trial workflows.
• MICS Medical Centers Owned clinical research sites including Warsaw, Toruń, Bydgoszcz and Szczecin (Poland) providing dedicated facilities for clinical trial execution with established patient recruitment capabilities, having conducted over 100 clinical trials from phase I to IV.

Quantifiable outcome

• 750+ clinical trials delivered over the past decade
• +3 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered strategic.

• Frontage LaboratoriesstrategicTechnology or Integration · 1 November 2024Strategic collaboration to expand global genomic testing services. Combines Medicover MICS's central lab capabilities with Frontage's genomic testing expertise to provide enhanced services for clinical trial sponsors.
• ARUP LaboratoriesstrategicTechnology or Integration · 6 December 2023Partnership to expand access to companion diagnostic in the European Union. ARUP developed the AAV5 DetectCDx Kit, the first ARUP test developed to support a new therapy (Roctavian). Partnership enables EU access to companion diagnostic testing.

Scale indicators16 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• SYNLAB Group: SYNLAB is a European leader in medical diagnostics and central laboratory services. MICS acquired SYNLAB's CEE businesses in 2025, making SYNLAB a direct central-lab competitor in remaining geographies and a clear capability benchmark.
• ARUP Laboratories: ARUP is a US reference laboratory operating companion diagnostic testing services (e.g., AAV5 DetectCDx). MICS is ARUP's EU distribution partner on Roctavian, making ARUP a direct peer in CDx/central lab services for clinical trial and commercial testing.
• Frontage Laboratories: Frontage provides bioanalytical, CMC, and genomic/CRO services supporting clinical trials. MICS announced a 2024 strategic collaboration with Frontage specifically to expand genomic testing, making Frontage both a partner and an adjacent comparable in CDx/genomic trial services.
• IQVIA (incl. Q² Solutions central labs): IQVIA operates full-service CRO and clinical trial central laboratory services (via Q² Solutions). It is one of the largest end-to-end competitors to MICS, serving the same pharma/biotech sponsors with global central lab + clinical operations bundled offerings.
• Cerba HealthCare / Cerba Research: Cerba operates central laboratory and specialty clinical trial testing services, including in Europe (with historical SYNLAB heritage). Direct peer of MICS for central lab and specialty diagnostic work supporting clinical trials.
• Labcorp (Fortrea for clinical trial services): Labcorp operates one of the largest global central laboratory networks serving clinical trials, plus Fortrea (spun off in 2023) as a dedicated CRO. MICS competes most directly with Labcorp's central lab business for sponsor trial work in pharma/biotech, particularly in EU/EMEA.
• Eurofins Scientific (Clinical Trial Services): Eurofins runs a global network of clinical trial testing and central laboratory services (Eurofins Central Laboratory, BioPharma Product Testing). Overlapping central lab, genomic, and bioanalytical capabilities make it a direct competitor to MICS for clinical trial sample analysis.

Broad incumbents

• ICON plc (including PRA Health and Mapi): ICON is one of the largest global CROs offering central lab, bioanalytical, and full-service clinical development. A broad incumbent competitor to MICS for outsourced trial services across all phases and therapeutic areas.
• Charles River Laboratories: Charles River operates a global research services platform with central laboratory, bioanalytical, and discovery services. Broad incumbent comparable to MICS for safety/clinical lab services supporting biopharma R&D.

Regional players

• Synevo (Medicover's diagnostics network): Synevo is Medicover Group's diagnostic network across CEE and a core operating subsidiary of MICS (Synevo Central Lab). As the sister unit, Synevo provides the diagnostic infrastructure underlying MICS and is itself a Central/Eastern European competitor in routine and reference lab services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/medicover-integrated-clinical-services-mics

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medicover Integrated Clinical Services